Marijuana use may not affect dental anesthetic requirements
Anesthesia medication dosage requirements may not need to be changed for regular marijuana users undergoing oral and maxillofacial surgery. The abstract was recently published in
Anesthesia medication dosage requirements may not need to be changed for regular marijuana users undergoing oral and maxillofacial surgery. The abstract was recently published in
Though many clinicians reported being concerned about the risk of paresthesia associated with articaine, the use of the anesthetic has expanded among dentists in the
The U.S. Patent and Trademark Office has issued a patent to Balanced Pharma for its dental anesthesia cartridge technology. BPI-001, the company’s new drug candidate,
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is evaluating whether anesthesia guidelines for oral surgeries need be updated for patients who take glucagonlike
A husband claims in a recent court filing that his 53-year-old wife has severe brain damage and requires around-the-clock care after an anesthesia mistake prior
A new tool uses LED lights to numb dental patients without using needles, according to clinical study being conducted by researchers at Griffiths University in
There are very few people who would consider having dental treatment without anesthesia. Preventive services and routine teeth cleanings aside, one of the top reasons
If you haven’t read part one of this two-part article, I suggest reading it now to glean the full scope of its message as it
In the world of dentistry, innovations that improve patient comfort and treatment efficiency are always welcome. One such innovation is poised to make waves in
A dentist in Florida voluntarily surrendered his dental license for administering general anesthesia to a patient with special needs and a history of seizures without
I still remember the very first day of learning dental anesthesia and injections in dental hygiene school. Do you remember that day as well? Even
With more patients taking glucagonlike peptide 1 (GLP-1) agonists like Ozempic to control diabetes and obesity, clinicians may need to rethink how to manage them